OAGV group (n = 8) | CAGV group (n = 12) | p-value | |
---|---|---|---|
Age, years (mean ± SD) | 60.9 ± 19.6 | 63.1 ± 14.1 | 0.910a |
Female, patients (%) | 4 (50.0%) | 6 (50.0%) | 0.350b |
Diabetes, patients (%) | 1 (12.5%) | 4 (33.3%) | 0.255b |
Hypertension, patients (%) | 2 (25.0%) | 2 (16.7%) | 0.381b |
Diagnosis, eyes (%) | 0.951b | ||
Neovascular glaucoma | 1 (12.5%) | 2 (16.7%) | |
Uveitic glaucoma | 1 (12.5%) | 1 (8.3%) | |
Pseudoexfoliation glaucoma | 1 (12.5%) | 3 (25.0%) | |
Primary open-angle glaucoma | 2 (25.0%) | 4 (33.4%) | |
Congenital glaucoma | 2 (25.0%) | 1 (8.3%) | |
Primary angle-closure glaucoma | 1 (12.5%) | 1 (8.3%) | |
Previous glaucoma surgery, eyes (%) | 4 (50.0%) | 6 (50.0%) | 1.000b |
Preoperative IOP (mean ± SD) | 33.4 ± 6.3 | 30.6 ± 6.8 | 0.238a |
Number of preoperative IOP-lowering medications (mean ± SD) | 3.6 ± 1.2 | 4.0 ± 1.2 | 0.473a |